Urinary collagen metabolite excretion in amyotrophic lateral sclerosis

Muscle and Nerve

Volumn 24, Issue 6, 2001, Pages 821-825

  Ono, Seiitsu ^a   Shimizu, Natsue ^a   Imai, Takashi ^b   Rodriguez, Gladys P ^c  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Chiba Higashi Hospital   (Japan)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Amyotrophic lateral sclerosis; Collagen; Glycoside; Hydroxylysine; Urine

Indexed keywords

COLLAGEN; GALACTOSE; GLUCOSE DERIVATIVE; GLYCOSIDE; LYSINE DERIVATIVE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; COLLAGEN METABOLISM; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; MALE; MOTOR NEURON DISEASE; MUSCLE WEAKNESS; PRIORITY JOURNAL; URINARY EXCRETION;

AGED; BIOLOGICAL MARKERS; COLLAGEN; FEMALE; HUMANS; HYDROXYLYSINE; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; REFERENCE VALUES; REGRESSION ANALYSIS; TIME FACTORS;

EID: 0035017540     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.1075     Document Type: Article

References (22)

1. Askenasi R. Urinary hydroxylysine and hydroxylysyl glycoside excretion in normal and pathologic states. J Lab Clin Med 1974;83:673-679.
2. Bisbee WC, Kelleher PC. A method for measuring hydroxylysine and glycosylated hydroxylysines in urine and protein hydrolysates. Clin Chim Acta 1978;90:29-36.
3. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994;124(suppl):96-107.
4. Brownell B, Oppenheimer DR, Hughes JT. The central nervous system in motor neuron disease. J Neurol Neurosurg Psychiatry 1970;33:338-357.
5. Claus-Walker J, Singh J, Leach CS, Hatton DV, Hubert CW, Ferrante ND. The urinary excretion of collagen degradation products by quadriplegic patients and during weightlessness. J Bone Joint Surg 1977;59A:209-212.
6. Furukawa T, Toyokura Y. Amyotrophic lateral sclerosis and bedsores. Lancet 1976;1:862.
7. Mathoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J 1965;14:61-65.
8. Ono S, Imai T, Munakata S, Takahashi K, Kanda F, Hashimoto K, Yamano T, Shimizu N, Nagao K, Yamauchi M. Collagen abnormalities in the spinal cord from patients with amyotrophic lateral sclerosis. J Neurol Sci 1998;160:140-147.
9. Ono S, Imai T, Takahashi K, Jinnai K, Kanda F, Fukuoka Y, Hashimoto K, Shimizu N, Nagao K. Alteration in amino acids in motor neurons of the spinal cord in amyotrophic lateral sclerosis. J Neurol Sci 1999;167:121-126.
10. Ono S, Imai T, Takahashi K, Jinnai K, Yamano T, Nagao K, Shimizu N, Yamauchi M. Decreased type IV collagen of skin and serum in patients with amyotrophic lateral sclerosis. Neurology 1988;51:114-120.
11. Ono S, Mechanic GL, Yamauchi M. Amyotrophic lateral sclerosis: unusually low content of collagen in skin. J Neurol Sci 1990;100:234-237.
12. Ono S, Yamauchi M. Amyotrophic lateral sclerosis: increased solubility of skin collagen. Neurology 1992;42:1535-1539.
13. Ono S, Yamauchi M. Collagen cross-linking of skin in patients with amyotrophic lateral sclerosis. Ann Neurol 1992;31:305-310.
14. Pinnell SR, Fox R, Krane SM. Human collagens: differences in glycosylated hydroxylysines in skin and bone. Collagen metabolite excretion as a predictor of bone- and skin-related complications Biochim Biophys Acta 1971;229:119-122.
15. Rodriguez GP, Claus-Walker J. Measurement of hydroxylysine glycosides in urine and its application to spinal cord injury. J Chromatograph 1984;308:65-73.
16. Rodriguez GP, Claus-Walker J, Kent MC, Garza HM. Collagen metabolite excretion as a predictor of bone-and skin-related complications in spinal cord injury. Arch Phys Med Rehabil 1989;70:442-444.
17. Rodriguez GP, Garber SL. Prospective study of pressure ulcer risk in spinal cord injury patients. Paraplegia 1994;32:150-158.
18. Segrest JP, Cunningham LW. Variations in human urinary O-hydroxylysyl glycoside levels and their relationship to collagen metabolism. J Clin Invest 1970;49:1497-1509.
19. Toyokura Y. A remarkable absence of decubitus formation in patients with amyotrophic lateral sclerosis. Neurol Med Chir (Tokyo) 1975;2:215-217.
20. Toyokura Y. Amyotrophic lateral sclerosis: a clinical and pathological study on the "negative features" of the disease. Jpn J Med 1977;16:269-273.
21. Uebayashi Y, Yase Y, Tanaka H, Shimada Y, Toyokura Y. Prognosis of motor neuron disease in Japan. Neuroepidemiology 1983;2:243-256.
22. Young JS, Burns PE. Pressure sores and spinal cord injuries. Sci Digest 1981;3:9-17.